Whittier Trust Co. recently reduced its stake in The Walt Disney Company (NYSE:DIS) by 11.7%, selling 41,190 shares but still retaining over 311,000 shares valued at approximately $35.73 million. This comes as Disney beat earnings expectations in its most recent quarter with an EPS of $1.63 and revenue of $25.98 billion, up 5.2% year-over-year. Despite institutional selling and buying, Wall Street analysts maintain a "Moderate Buy" consensus rating for DIS, with an average target price of $132.19.

HC Wainwright has reissued a "Buy" rating for Avino Silver & Gold Mines (NYSE:ASM) with a price target of $12.50, suggesting a significant upside of 73.61%. The company has a consensus "Moderate Buy" rating from analysts with an average price target of $9.50. Avino (ASM) opened at $7.20 with a market cap of $1.21 billion and a PE ratio of 360.

Whittier Trust Co. increased its stake in United Rentals (NYSE:URI) by 2.6% in the fourth quarter, purchasing an additional 1,529 shares to hold a total of 61,408 shares valued at $54.78 million. Other institutional investors also adjusted their positions in the construction company. Despite missing Q4 EPS estimates, United Rentals' board approved a $5.00 billion share buyback and raised its quarterly dividend to $1.97 per share.

Pratt & Whitney Canada, an RTX business, has introduced new maintenance, repair, and overhaul (MRO) services for helicopter and regional turboprop engines at its Singapore facility. This expansion specifically targets the PT6C-67C and PW127XT engines, enhancing support for the Leonardo AW139 helicopters and ATR 42/72 aircraft in the Asia Pacific region. The new services aim to meet rising demand, offer advanced localized maintenance solutions, and reduce turnaround times for customers.

UnitedHealth Group operates with a unique integrated healthcare model, combining its UnitedHealthcare insurance arm with Optum's diverse health services. This structure, which includes pharmacies, clinics, and data analytics, aims to improve patient outcomes and cut costs, driving consistent revenue growth and robust free cash flow. The article suggests this model positions UnitedHealth favorably against competitors, making it an attractive long-term investment in the growing U.S. healthcare market and

AT&T Inc. is strategically focusing on fiber broadband expansion and wireless services after divesting non-core assets like WarnerMedia, aiming to capitalize on the surging demand for high-speed internet. The company's aggressive fiber rollout, targeting 30 million locations by 2025, is enhancing its competitive edge and driving revenue growth with lower churn and premium pricing. While debt levels remain a consideration, analysts view AT&T as a stable, income-focused investment, particularly attractive to those seeking dividend yield and exposure to essential telecom infrastructure in the U.S.

DuPont (NYSE: DD) announced it won two 2026 Edison Awards for its FilmTec™ Fortilife™ XC160UHP, recognized for industrial water reuse, and Tychem® 6000 SFR, honored for worker protection against chemical splash and flash-fire hazards. These awards highlight DuPont's commitment to innovation in sustainability and safety, addressing critical industry challenges with advanced solutions. The technologies aim to improve environmental performance and ensure worker safety across various sectors.

GM Financial announced its 2025 Auction of the Year winners, recognizing five regional auctions and one Most Valuable Auction for their high performance in remarketing. The company also awarded two auctions with the Perfect Audit Score. These awards, part of the annual Auction of Excellence program, highlight locations excelling in retention, operational metrics, and overall auction operations.

The Gross Law Firm has issued a shareholder alert for Atara Biotherapeutics, Inc. (NASDAQ: ATRA), announcing a lead plaintiff deadline of May 22, 2026, for a securities class action lawsuit. The lawsuit alleges that during the period of May 20, 2024, to January 9, 2026, the company made false or misleading statements regarding manufacturing issues and the regulatory prospects of its drug tabelecleucel. Shareholders who purchased ATRA shares during this period are encouraged to contact the firm to potentially be appointed as lead plaintiff.

This article examines Salesforce, Inc.'s position in the global markets, focusing on its CRM solutions and increasing integration of AI. It highlights Salesforce's subscription-based SaaS model, its AI pivot with Einstein AI, and its competitive standing against rivals like Microsoft Dynamics and Oracle. The piece evaluates the company's significance for U.S. and global investors, considering analyst views, potential risks, and its strategic outlook driven by AI and digital transformation.